# Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions

> **NCT00835393** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pantoprazole Sodium 40 mg delayed-release tablets
- **DRUG:** PROTONIX® 40 mg delayed-release tablets.

## Key facts

- **NCT ID:** NCT00835393
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2009-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00835393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00835393, "Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00835393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*